Novel treatment for sciatica provides pain relief beyond one month: C.L.E.A.R. trial Medha Baranwal7 April 2022 9:00 AM ISTUSA: Findings released from phase 3 C.L.E.A.R. trial evaluating safety and treatment of SP-102 (injectable dexamethasone sodium phosphate viscous gel)...
External Trigeminal Nerve Stimulation device effective for At-Home Acute Migraine Treatment: Phase 3 Clinical Trial Dr. Kamal Kant Kohli7 April 2022 6:00 AM IST DARIEN, CEFALY Technology, a Belgium-based manufacturer of wearable medical devices for migraine, today announced the results of a clinical...
IBD patients in remission may have Mental health issues, low productivity at work MD Editorial Team7 April 2022 5:54 AM ISTInflammatory bowel disease (IBD) is a term for two conditions (Crohn's disease and ulcerative colitis) that are characterized by chronic inflammation...
Lamotrigine and levetiracetam reasonable first-line treatment options for patients with poststroke epilepsy: JAMA Medical Dialogues Editorial Team6 April 2022 9:00 AM ISTSweden: Recent research found disparities in survival among individuals treated with various antiseizure medications (ASM) for poststroke epilepsy....
Two-way relationship exists between daytime naps and dementia in elderly: Study Isra Zaman6 April 2022 9:00 AM ISTOlder adults with increased napping habits during the daytimes suffer from higher risks of Alzheimer's dementia while the patients with Alzheimer's...
Dementia on rise- Half of older adults now die with a dementia diagnosis: JAMA Dr. Kamal Kant Kohli5 April 2022 9:15 AM ISTNearly half of all older adults now die with a diagnosis of dementia listed on their medical record, up 36% from two decades ago, a new study shows. ...
Investigational Anti-Clotting Drug Asundexian cuts Bleeding Risk Among AF Patients: Lancet Dr. Kamal Kant Kohli5 April 2022 9:00 AM ISTDURHAM, N.C-A new type of anti-clotting drug Asundexian, caused fewer bleeding incidents among patients with atrial fibrillation than the commonly...
Experimental drug may reduce tics in children and teens with Tourette Syndrome Dr. Kamal Kant Kohli4 April 2022 9:00 AM ISTMINNEAPOLIS - According to a new preliminary study, children and teens with Tourette syndrome who are treated with an experimental drug called...
Diabetic sensorimotor polyneuroneuropathy associated with orthostatic blood pressure changes Medha Baranwal2 April 2022 10:00 AM ISTCanada: Patients with diabetic sensorimotor polyneuropathy (DSP) frequently experience orthostatic hypertension and orthostatic hypotension, states a...
Tea intake reduces abdominal aortic aneurysm risk, study finds Medical Dialogues Editorial Team2 April 2022 9:00 AM ISTSweden: A group of scientists led by Joanna Kaluza conducted a new study in which they showed that Tea intake was linked to a lower risk of abdominal...
ACS releases revised mobility guidelines for spinal injury patients Isra Zaman2 April 2022 9:00 AM ISTAlthough the post-traumatic spinal cord injury represents only a small fraction of all fractures and the rate of incidence ranges from 4-23%, the...
Scientists at Sage Therapeutics develop safe, effective Alzheimer's drug Isra Zaman2 April 2022 9:00 AM ISTA new experimental drug, called SAGE-718 has been found to exhibit improved executive function,thinking and memory skills in Alzheimer's patients with...
